Uncontrolled Disseminated Intravascular Coagulation (DIC)
Subject has clinical evidence of Disseminated Intravascular Coagulation
Have evidence of uncontrolled disseminated intravascular coagulation
Patients must have no clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS leukemia
Immediate life-threatening, severe complications of leukemia such as uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated intravascular coagulation
FOR AML ONLY: Absence of uncompensated disseminated intravascular coagulation (DIC- as diagnosed by standard International Society on Thrombosis and Hemostasis [ISTH] criteria)
AML ONLY: Current disseminated intravascular coagulopathy (DIC)
Has an active bleeding disorders or evidence of chronic or acute disseminated intravascular coagulation (DIC)
Patients must have no clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS leukemia
Have evidence of uncontrolled disseminated intravascular coagulation
Clinically significant coagulation abnormality, such as disseminated intravascular coagulation.
Have immediate, life-threatening, severe complications of leukemia, such as uncontrolled bleeding, pneumonia with hypoxia or sepsis, and/or disseminated intravascular coagulation.
Disseminated intravascular coagulopathy with active bleeding or signs of thrombosis
Subject has clinical evidence of Disseminated Intravascular Coagulation (DIC)
Subject has clinically significant abnormality of coagulation profile, such as disseminated intravascular coagulation (DIC).
Clinically significant coagulation abnormality, such as disseminated intravascular coagulation.
Subjects with immediately life-threatening, severe complications of leukemia such as uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated intravascular coagulation.
Has clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS multiple myeloma
Subjects who have had clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS multiple myeloma, or plasma cell leukemia
Subjects who have had clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS leukemia.
Has clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS multiple myeloma
Has acute promyelocytic leukemia, clinically uncontrolled disseminated intravascular coagulation, or peripheral cytopenia
Hereditary or acquired coagulopathies (e.g., hemophilia, von Willebrand disease, or cancer associated disseminated intravascular coagulation [DIC])
History of bleeding (i.e. disseminated intravascular coagulation or clotting factor deficiency);
Subject has disseminated intravascular coagulation abnormality (DIC).
Subjects with immediately life-threatening, severe complications of leukemia such as uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated intravascular coagulation.
Uncontrolled disseminated intravascular coagulation.
Absence of coagulopathy (no uncompensated disseminated intravascular coagulation, DIC) at screening
Clinical picture indicative of leukostasis or evidence of disseminated intravascular coagulopathy
Patients with laboratory findings consistent with grade equal to greater than 3 disseminated intravascular coagulation (DIC) or any grade 2 DIC that does not correct
Active bleeding disorders or evidence of evidence of chronic or acute disseminated intravascular coagulation (DIC)
Subject has disseminated intravascular coagulation abnormality (DIC)
Patients must have no clinical evidence of central nervous system (CNS) or pulmonary leukostasis, disseminated intravascular coagulation, or CNS leukemia
Serious concurrent medical problems, uncontrolled infections, or disseminated intravascular coagulopathy (DIC), hepatic cirrhosis, or chronic kidney disease.
Disseminated intravascular coagulation
History of known bleeding disorder (i.e. disseminated intravascular coagulation or clotting factor deficiency);
Evidence of disseminated intravascular anticoagulation (DIC) as determined by the patientâ€™s primary provider
Coagulopathies including disseminated intravascular coagulation (DIC), receiving anticoagulant or antiplatelet agents
Known diagnosis of disseminated intravascular coagulation (DIC)
Known diagnosis of disseminated intravascular coagulation
